Brendan Hannah
Director of Finance/CFO at QUINCE THERAPEUTICS, INC.
Net worth: 207 602 $ as of 2024-04-29
Profile
Brendan Hannah is currently the COO, Chief Financial & Accounting Officer at Quince Therapeutics, Inc. and also holds the position of Chief Operating Officer at Novosteo, Inc. Previously, he worked as the Director of Business Development at Cidara Therapeutics, Inc. and as the Chief Business Officer at Neuroptika, Inc. Mr. Hannah obtained an MBA from the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 201,555 ( 0.47% ) | 207 602 $ | 2024-04-29 |
Brendan Hannah active positions
| Companies | Position | Start |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director of Finance/CFO | 2023-03-15 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - |
Former positions of Brendan Hannah
| Companies | Position | End |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 2016-11-30 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Brendan Hannah
| University of California | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Brendan Hannah